• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STIMWAVE/CURONIX LLC STIMWAVE STQ4; STIMULATOR, PERIPHERAL NERVE, IMPLANTED (PAIN RELIEF)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STIMWAVE/CURONIX LLC STIMWAVE STQ4; STIMULATOR, PERIPHERAL NERVE, IMPLANTED (PAIN RELIEF) Back to Search Results
Model Number STQ4-SPR-B0
Health Effect - Clinical Code Inadequate Pain Relief (2388)
Date of Event 12/21/2023
Type of Reportable Event Serious Injury
Event or Problem Description
Saw on the news that stimwave has filed for bankruptcy in 2022 and the ceo was arrested for various types of fraud, i.E.Insurance etc.All stimwave devices based on my own research has shown that my particular device is on the fda recall list.The device never really worked to relieve my pain.I reached out to the company that has taken over for stimwave on 12/26/2013 and they have my file and they are working on having someone contact me with further guidance regarding this matter.Reference report: #mw5149658.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STIMWAVE STQ4
Common Device Name
STIMULATOR, PERIPHERAL NERVE, IMPLANTED (PAIN RELIEF)
Manufacturer (Section D)
STIMWAVE/CURONIX LLC
MDR Report Key18418260
Report NumberMW5149659
Device Sequence Number19704804
Product Code GZF
Combination Product (Y/N)N
Initial Reporter StateMA
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Reporter Type Voluntary
Initial Reporter Occupation Patient
Type of Report Initial
Report Date (Section B) 12/26/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Model NumberSTQ4-SPR-B0
Was Device Available for Evaluation? Yes
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date12/28/2023
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
COMBIVENT.; DEXILANT.; DULERA. ; EFFEXOR.; FAMOTIDINE.; FINASTERIDE.; LATANOPROST.; LINZESS.; PREGABALIN.; PROPRANOLOL.; RESPIMAT.; STIMWAVE.; TRAZODONE.
Outcome Attributed to Adverse Event Required Intervention;
Patient Age50 YR
Patient SexMale
Patient Weight95 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-